Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy.
Hsu ML, Murray JC, Psoter KJ, Zhang J, Barasa D, Brahmer JR, Ettinger DS, Forde PM, Hann CL, Lam VK, Levy B, Marrone KA, Patel T, Peterson V, Sagorsky S, Turner M, Anagnostou V, Naidoo J, Feliciano JL.
Hsu ML, et al.
Oncologist. 2022 Nov 3;27(11):971-981. doi: 10.1093/oncolo/oyac140.
Oncologist. 2022.
PMID: 35972337
Free PMC article.